| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 0XMR8L9LOL |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myasthenia Gravis | 2 | D009157 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 2 | D016553 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
| Autoimmune Diseases | 1 | D001327 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297833 |
| FDA SRS | 0XMR8L9LOL |
CONTENTS